Home ETF List About

Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for GERN

Stock NameGeron Corporation
TickerGERN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS3741631036
LEI549300T282D7Z2YESL90

Show aggregate GERN holdings

News associated with GERN

Chicago Partners Investment Group LLC Grows Stock Position in Geron Corporation (NASDAQ:GERN)
Chicago Partners Investment Group LLC grew its position in Geron Corporation (NASDAQ:GERN – Free Report) by 143.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 41,448 shares of the biopharmaceutical company’s stock after acquiring an additional 24,389 shares during […] - 2025-08-13 04:52:49
Brokerages Set Geron Corporation (NASDAQ:GERN) PT at $4.19
Shares of Geron Corporation (NASDAQ:GERN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, four have issued a buy […] - 2025-08-12 02:30:48
Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Geron Corporation (NASDAQ:GERN)
Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Geron Corporation (NASDAQ:GERN – Free Report) during the 1st quarter, HoldingsChannel reports. The fund purchased 39,643 shares of the biopharmaceutical company’s stock, valued at approximately $63,000. Several other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its […] - 2025-08-06 04:31:10
Brokerages Set Geron Corporation (NASDAQ:GERN) Target Price at $4.61
Shares of Geron Corporation (NASDAQ:GERN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, five have assigned a buy recommendation and one […] - 2025-07-18 02:22:58
Sowell Financial Services LLC Invests $43,000 in Geron Corporation (NASDAQ:GERN)
Sowell Financial Services LLC purchased a new position in shares of Geron Corporation (NASDAQ:GERN – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 27,000 shares of the biopharmaceutical company’s stock, valued at approximately $43,000. Several other institutional […] - 2025-06-24 05:18:52
Exchange Traded Concepts LLC Grows Holdings in Geron Corporation (NASDAQ:GERN)
Exchange Traded Concepts LLC lifted its position in shares of Geron Corporation (NASDAQ:GERN – Free Report) by 91.0% during the 1st quarter, HoldingsChannel reports. The fund owned 73,211 shares of the biopharmaceutical company’s stock after purchasing an additional 34,890 shares during the period. Exchange Traded Concepts LLC’s holdings in Geron were worth $116,000 at the […] - 2025-06-24 04:38:54
Geron Corporation (NASDAQ:GERN) Given Average Rating of “Moderate Buy” by Brokerages
Geron Corporation (NASDAQ:GERN – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average […] - 2025-06-20 03:08:48
Geron Co. (NASDAQ:GERN) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 24.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,267,176 shares of the biopharmaceutical […] - 2025-06-04 05:00:53
Geron Co. (NASDAQ:GERN) Receives $5.06 Average Target Price from Brokerages
Shares of Geron Co. (NASDAQ:GERN – Get Free Report) have received an average rating of “Moderate Buy” from the nine research firms that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-29 02:27:25
Deutsche Bank AG Grows Stake in Geron Co. (NASDAQ:GERN)
Deutsche Bank AG increased its holdings in shares of Geron Co. (NASDAQ:GERN – Free Report) by 24.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 892,910 shares of the biopharmaceutical company’s stock after acquiring an additional 174,156 shares during the period. Deutsche Bank AG’s holdings in Geron were worth $3,161,000 at the end of […] - 2025-05-21 04:42:56
Wedbush Forecasts Geron’s Q2 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – Equities researchers at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for Geron in a research note issued on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will post earnings of ($0.02) per share for the quarter, up from their prior […] - 2025-05-13 03:04:50
Geron Co. (NASDAQ:GERN) Shares Sold by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company lowered its holdings in Geron Co. (NASDAQ:GERN – Free Report) by 35.5% in the fourth quarter, HoldingsChannel reports. The firm owned 448,886 shares of the biopharmaceutical company’s stock after selling 246,649 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Geron were worth $1,589,000 as of its most […] - 2025-05-12 05:36:48
Voya Investment Management LLC Has $872,000 Holdings in Geron Co. (NASDAQ:GERN)
Voya Investment Management LLC grew its position in Geron Co. (NASDAQ:GERN – Free Report) by 30.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 246,282 shares of the biopharmaceutical company’s stock after purchasing an additional 58,034 shares during the period. Voya Investment Management LLC’s holdings in Geron were worth $872,000 at the end […] - 2025-05-07 06:32:51
Integrated Wealth Concepts LLC Invests $36,000 in Geron Co. (NASDAQ:GERN)
Integrated Wealth Concepts LLC acquired a new stake in shares of Geron Co. (NASDAQ:GERN – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,285 shares of the biopharmaceutical company’s stock, valued at approximately $36,000. A number of other large […] - 2025-05-07 05:56:53
Wells Fargo & Company MN Buys 71,697 Shares of Geron Co. (NASDAQ:GERN)
Wells Fargo & Company MN grew its stake in Geron Co. (NASDAQ:GERN – Free Report) by 22.3% in the 4th quarter, Holdings Channel reports. The firm owned 392,696 shares of the biopharmaceutical company’s stock after purchasing an additional 71,697 shares during the period. Wells Fargo & Company MN’s holdings in Geron were worth $1,390,000 at […] - 2025-04-28 04:34:48
Invesco Ltd. Sells 385,925 Shares of Geron Co. (NASDAQ:GERN)
Invesco Ltd. reduced its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 15.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,077,602 shares of the biopharmaceutical company’s stock after selling 385,925 shares during the period. Invesco Ltd. owned […] - 2025-04-25 05:34:54
JPMorgan Chase & Co. Decreases Position in Geron Co. (NASDAQ:GERN)
JPMorgan Chase & Co. decreased its stake in Geron Co. (NASDAQ:GERN – Free Report) by 4.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 498,730 shares of the biopharmaceutical company’s stock after selling 20,944 shares during the quarter. JPMorgan Chase & Co.’s holdings […] - 2025-04-25 04:57:01
Leerink Partnrs Predicts Geron’s Q2 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for shares of Geron in a research report issued to clients and investors on Monday, April 21st. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will earn ($0.04) per share for the quarter, down […] - 2025-04-24 02:52:48
Renaissance Technologies LLC Takes Position in Geron Co. (NASDAQ:GERN)
Renaissance Technologies LLC acquired a new position in shares of Geron Co. (NASDAQ:GERN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,452,700 shares of the biopharmaceutical company’s stock, valued at approximately $5,143,000. Several other institutional […] - 2025-04-21 04:46:47
Geron Co. (NASDAQ:GERN) Stock Position Decreased by Alliancebernstein L.P.
Alliancebernstein L.P. reduced its stake in shares of Geron Co. (NASDAQ:GERN – Free Report) by 49.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 625,291 shares of the biopharmaceutical company’s stock after selling 604,491 shares during the quarter. Alliancebernstein L.P.’s holdings in Geron were worth $2,214,000 as of its most recent SEC […] - 2025-04-17 04:29:03
ExodusPoint Capital Management LP Purchases New Position in Geron Co. (NASDAQ:GERN)
ExodusPoint Capital Management LP acquired a new position in shares of Geron Co. (NASDAQ:GERN – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 106,441 shares of the biopharmaceutical company’s stock, valued at approximately $377,000. A number of other institutional investors and hedge funds have also bought and sold shares of the […] - 2025-04-13 05:57:04
Geron Co. (NASDAQ:GERN) Shares Purchased by Sei Investments Co.
Sei Investments Co. boosted its holdings in shares of Geron Co. (NASDAQ:GERN – Free Report) by 6.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 189,614 shares of the biopharmaceutical company’s stock after buying an additional 12,027 shares during the […] - 2025-04-09 04:58:43
Geron Co. (NASDAQ:GERN) Receives $5.75 Consensus Price Target from Analysts
Geron Co. (NASDAQ:GERN – Get Free Report) has been given an average rating of “Moderate Buy” by the eleven research firms that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-04-09 02:05:01
Geron (NASDAQ:GERN) Hits New 52-Week Low – Here’s What Happened
Geron Co. (NASDAQ:GERN – Get Free Report) hit a new 52-week low during trading on Wednesday . The stock traded as low as $1.45 and last traded at $1.48, with a volume of 31179782 shares trading hands. The stock had previously closed at $1.59. Analyst Ratings Changes A number of research analysts have weighed in […] - 2025-04-02 05:14:53
Corient Private Wealth LLC Grows Holdings in Geron Co. (NASDAQ:GERN)
Corient Private Wealth LLC lifted its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 58.7% during the 4th quarter, HoldingsChannel reports. The fund owned 37,585 shares of the biopharmaceutical company’s stock after purchasing an additional 13,896 shares during the period. Corient Private Wealth LLC’s holdings in Geron were worth $133,000 at the […] - 2025-04-02 04:22:51
Teacher Retirement System of Texas Purchases 39,933 Shares of Geron Co. (NASDAQ:GERN)
Teacher Retirement System of Texas raised its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 35.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 151,887 shares of the biopharmaceutical company’s stock after buying an additional 39,933 shares during the quarter. Teacher Retirement System of Texas’ holdings in Geron were worth $538,000 […] - 2025-04-01 04:40:46
Swiss National Bank Grows Position in Geron Co. (NASDAQ:GERN)
Swiss National Bank raised its holdings in shares of Geron Co. (NASDAQ:GERN – Free Report) by 15.7% during the fourth quarter, HoldingsChannel reports. The firm owned 1,007,800 shares of the biopharmaceutical company’s stock after purchasing an additional 136,400 shares during the period. Swiss National Bank’s holdings in Geron were worth $3,568,000 as of its most […] - 2025-03-26 05:44:44
Bank of New York Mellon Corp Sells 9,621 Shares of Geron Co. (NASDAQ:GERN)
Bank of New York Mellon Corp lowered its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 0.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,649,422 shares of the biopharmaceutical company’s stock after selling 9,621 shares during the quarter. Bank of New York Mellon Corp’s holdings in Geron were worth $5,839,000 […] - 2025-03-17 06:01:01
Geron (NASDAQ:GERN) versus Dermata Therapeutics (NASDAQ:DRMA) Head-To-Head Review
Geron (NASDAQ:GERN – Get Free Report) and Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Analyst Recommendations This is a summary of current […] - 2025-03-12 04:10:56
B. Riley Comments on Geron’s FY2027 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – B. Riley decreased their FY2027 earnings estimates for shares of Geron in a research note issued to investors on Tuesday, February 18th. B. Riley analyst K. Patel now forecasts that the biopharmaceutical company will post earnings of $0.28 per share for the year, down from their prior forecast […] - 2025-02-21 06:30:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) GERN holdings

DateNumber of GERN Shares HeldBase Market Value of GERN SharesLocal Market Value of GERN SharesChange in GERN Shares HeldChange in GERN Base ValueCurrent Price per GERN Share HeldPrevious Price per GERN Share Held
2025-11-11 (Tuesday)405,735USD 507,169GERN holding increased by 36516USD 507,1690USD 36,516 USD 1.25 USD 1.16
2025-11-10 (Monday)405,735GERN holding increased by 1052USD 470,653GERN holding increased by 37642USD 470,6531,052USD 37,642 USD 1.16 USD 1.07
2025-11-07 (Friday)404,683USD 433,011GERN holding decreased by -4047USD 433,0110USD -4,047 USD 1.07 USD 1.08
2025-11-06 (Thursday)404,683GERN holding increased by 1052USD 437,058GERN holding decreased by -2900USD 437,0581,052USD -2,900 USD 1.08 USD 1.09
2025-11-05 (Wednesday)403,631USD 439,958GERN holding decreased by -24218USD 439,9580USD -24,218 USD 1.09 USD 1.15
2025-11-04 (Tuesday)403,631GERN holding increased by 1057USD 464,176GERN holding decreased by -18913USD 464,1761,057USD -18,913 USD 1.15 USD 1.2
2025-11-03 (Monday)402,574USD 483,089GERN holding decreased by -24154USD 483,0890USD -24,154 USD 1.2 USD 1.26
2025-10-31 (Friday)402,574USD 507,243GERN holding increased by 8051USD 507,2430USD 8,051 USD 1.26 USD 1.24
2025-10-30 (Thursday)402,574GERN holding increased by 5280USD 499,192GERN holding increased by 10520USD 499,1925,280USD 10,520 USD 1.24 USD 1.23
2025-10-29 (Wednesday)397,294GERN holding increased by 2112USD 488,672GERN holding decreased by -17161USD 488,6722,112USD -17,161 USD 1.23 USD 1.28
2025-10-28 (Tuesday)395,182USD 505,833USD 505,8330USD 0 USD 1.28 USD 1.28
2025-10-27 (Monday)395,182USD 505,833GERN holding increased by 15807USD 505,8330USD 15,807 USD 1.28 USD 1.24
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GERN by Blackrock for IE00BDZVHG35

Show aggregate share trades of GERN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY1,0521.1701.070 1.080USD 1,136 2.09
2025-11-06BUY1,0521.1101.050 1.056USD 1,111 2.10
2025-11-04BUY1,0571.2201.140 1.148USD 1,213 2.11
2025-10-30BUY5,2801.2801.220 1.226USD 6,473 2.13
2025-10-29BUY2,1121.2301.280 1.275USD 2,693 2.13
2025-10-22SELL-4,2001.2401.280 1.276USD -5,359 2.16 Profit of 3,708 on sale
2025-10-20BUY2,1001.2701.280 1.279USD 2,686 2.17
2025-10-17BUY5,2421.2001.240 1.236USD 6,479 2.18
2025-10-15BUY8,3361.2801.310 1.307USD 10,895 2.18
2025-10-03BUY7,3921.3501.480 1.467USD 10,844 2.19
2025-10-02BUY1,0541.3801.430 1.425USD 1,502 2.20
2025-09-30BUY2,1121.3701.390 1.388USD 2,931 2.21
2025-09-26BUY2,1121.2901.300 1.299USD 2,743 2.22
2025-09-25BUY2,1121.2701.360 1.351USD 2,853 2.22
2025-09-18BUY1,1311.3201.340 1.338USD 1,513 2.23
2025-09-17BUY3,4051.2701.340 1.333USD 4,539 2.23
2025-07-17SELL-2,2301.2901.330 1.326USD -2,957 2.26 Profit of 2,082 on sale
2025-07-11SELL-8,9601.3201.380 1.374USD -12,311 2.29 Profit of 8,164 on sale
2025-07-02BUY61,5451.4001.460 1.454USD 89,486 2.31
2025-06-25BUY2,2301.5201.560 1.556USD 3,470 2.33
2025-06-20BUY18,2511.5101.580 1.573USD 28,709 2.35
2025-06-11BUY2,1201.5401.620 1.612USD 3,417 2.39
2025-06-10BUY2,1201.6001.650 1.645USD 3,487 2.40
2025-06-04SELL-1,0601.5401.590 1.585USD -1,680 2.42 Profit of 890 on sale
2025-04-23BUY1,0581.3901.470 1.462USD 1,547 2.75
2025-04-10SELL-8,4481.3001.350 1.345USD -11,363 2.89 Profit of 13,056 on sale
2025-04-08SELL-1,0541.2801.450 1.433USD -1,510 2.93 Profit of 1,574 on sale
2025-04-07SELL-1,0561.4101.430 1.428USD -1,508 2.94 Profit of 1,601 on sale
2025-04-04SELL-5,2951.3801.470 1.461USD -7,736 2.96 Profit of 7,949 on sale
2025-04-01BUY4,3681.4801.600 1.588USD 6,936 3.00
2025-03-31SELL-3,1861.5901.630 1.626USD -5,180 3.01 Profit of 4,421 on sale
2025-03-21BUY29,1371.8201.890 1.883USD 54,865 3.12
2025-03-14SELL-15,5361.6401.730 1.721USD -26,737 3.22 Profit of 23,218 on sale
2025-03-07SELL-1,9341.7301.800 1.793USD -3,468 3.33 Profit of 2,977 on sale
2025-03-04SELL-9681.6601.710 1.705USD -1,650 3.41 Profit of 1,651 on sale
2025-02-25BUY1,9262.3702.420 2.415USD 4,651 3.55
2025-02-19SELL-9582.5402.630 2.621USD -2,511 3.62 Profit of 958 on sale
2025-02-13BUY2,8652.7902.830 2.826USD 8,096 3.70
2025-02-12BUY9552.7902.820 2.817USD 2,690 3.72
2025-02-11BUY3,8202.7902.830 2.826USD 10,795 3.74
2024-12-30SELL-33,4703.4003.430 3.427USD -114,702 4.07 Profit of 21,541 on sale
2024-11-18SELL-15,6303.7803.860 3.852USD -60,207 4.14 Profit of 4,453 on sale
2024-11-08SELL-1,0424.2504.330 4.322USD -4,504 4.14 Loss of -189 on sale
2024-10-21SELL-1,0443.9504.100 4.085USD -4,265 0.00 Loss of -4,265 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GERN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-192,515,10603,740,43867.2%
2025-09-18837,54901,824,57445.9%
2025-09-171,542,051168,2383,124,41849.4%
2025-09-162,400,28911,5756,738,65135.6%
2025-09-151,081,3592,4592,068,02952.3%
2025-09-12986,3626,7172,109,45746.8%
2025-09-11898,2495,4031,970,18545.6%
2025-09-101,471,8554,7003,276,64544.9%
2025-09-09795,63501,617,20649.2%
2025-09-081,092,96302,461,46044.4%
2025-09-051,377,46202,628,29452.4%
2025-09-04833,95901,973,14742.3%
2025-09-031,842,27303,508,58752.5%
2025-09-021,650,27706,196,01126.6%
2025-08-29562,61101,306,28443.1%
2025-08-28706,51602,242,92731.5%
2025-08-27651,2058972,164,66030.1%
2025-08-26569,56601,191,66747.8%
2025-08-251,129,36802,628,16143.0%
2025-08-22819,84202,807,48129.2%
2025-08-21666,48001,642,44240.6%
2025-08-20871,70602,319,49737.6%
2025-08-191,021,81802,200,46846.4%
2025-08-183,358,18525,4359,466,34835.5%
2025-08-151,044,91005,769,72418.1%
2025-08-141,157,68403,848,67430.1%
2025-08-132,067,81419,350,05722.1%
2025-08-122,056,3373,0004,869,49042.2%
2025-08-113,715,4577808,173,65845.5%
2025-08-082,304,63213,9376,047,21038.1%
2025-08-074,191,1351367,214,91558.1%
2025-08-069,139,82532314,305,97663.9%
2025-08-052,193,0502,0464,314,89450.8%
2025-08-043,706,6154,7957,140,21651.9%
2025-08-013,110,5091,3155,312,38858.6%
2025-07-314,183,35219,5586,611,71063.3%
2025-07-302,471,9584054,107,75760.2%
2025-07-293,051,391373,0426,058,93850.4%
2025-07-284,989,38756,70512,385,61640.3%
2025-07-251,802,77514,3344,041,69744.6%
2025-07-243,786,6102,5506,366,26359.5%
2025-07-232,262,03913,1666,252,45936.2%
2025-07-222,057,7831,3463,951,86052.1%
2025-07-211,878,37416,1995,441,59534.5%
2025-07-181,907,2205,3702,860,66066.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.